Northern Trust Corp Karuna Therapeutics, Inc. Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$161.01 - $317.85 $284,504 - $561,640	1,767 Added 1.12%	159,328 $50.4 Million
Q3 2023 Nov 13, 2023	BUY	$164.66 - $218.08 $2.23 Million - $2.96 Million	13,566 Added 9.42%	157,561 $26.6 Million
Q2 2023 Aug 11, 2023	SELL	$176.32 - $240.22 $26.1 Million - $35.5 Million	-147,913 Reduced 50.67%	143,995 $31.2 Million
Q1 2023 May 15, 2023	BUY	$161.33 - $204.36 $3.66 Million - $4.63 Million	22,659 Added 8.42%	291,908 $53 Million
Q4 2022 Feb 13, 2023	BUY	$191.53 - $236.82 $1.17 Million - $1.44 Million	6,094 Added 2.32%	269,249 $52.9 Million
Q3 2022 Nov 14, 2022	BUY	$123.79 - $277.42 $3.87 Million - $8.68 Million	31,275 Added 13.49%	263,155 $59.2 Million
Q2 2022 Aug 12, 2022	BUY	$93.97 - $143.33 $2.38 Million - $3.63 Million	25,319 Added 12.26%	231,880 $29.3 Million
Q1 2022 May 13, 2022	SELL	$98.9 - $132.37 $891,385 - $1.19 Million	-9,013 Reduced 4.18%	206,561 $26.2 Million
Q4 2021 Feb 08, 2022	SELL	$110.64 - $159.4 $355,928 - $512,789	-3,217 Reduced 1.47%	215,574 $28.2 Million
Q3 2021 Nov 15, 2021	SELL	$101.2 - $125.87 $741,998 - $922,878	-7,332 Reduced 3.24%	218,791 $26.8 Million
Q2 2021 Aug 13, 2021	BUY	$107.45 - $135.95 $5.02 Million - $6.35 Million	46,741 Added 26.06%	226,123 $25.8 Million
Q1 2021 May 12, 2021	SELL	$95.46 - $133.08 $270,915 - $377,681	-2,838 Reduced 1.56%	179,382 $21.6 Million
Q4 2020 Feb 11, 2021	SELL	$75.23 - $109.23 $267,593 - $388,531	-3,557 Reduced 1.91%	182,220 $18.5 Million
Q3 2020 Nov 16, 2020	BUY	$71.31 - $109.74 $4.5 Million - $6.93 Million	63,153 Added 51.5%	185,777 $14.4 Million
Q2 2020 Aug 14, 2020	SELL	$62.14 - $117.21 $268,569 - $506,581	-4,322 Reduced 3.4%	122,624 $13.7 Million
Q1 2020 May 14, 2020	BUY	$60.41 - $115.92 $3.49 Million - $6.69 Million	57,732 Added 83.41%	126,946 $9.14 Million
Q4 2019 Feb 14, 2020	BUY	$11.44 - $123.99 $31,219 - $338,368	2,729 Added 4.1%	69,214 $5.22 Million
Q3 2019 Nov 13, 2019	BUY	$16.05 - $27.35 $1.07 Million - $1.82 Million	66,485 New	66,485 $1.09 Million
Q2 2019 Aug 13, 2019	BUY	$20.02 - $20.02 $0 - $0	0 New	0 $0

Others Institutions Holding KRTX

# of Institutions

Shares Held

332K

Call Options Held

Put Options Held

View Full List

About Karuna Therapeutics, Inc.

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

More about KRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account